Evolving strategies with immunomodulating drugs and tandem autologous/allogeneic hematopoietic stem cell transplantation in first line high risk multiple myeloma patients
Authors:
- Mauricette MichalletMMMauricette Michallet
- Mohamad SobhMSMohamad Sobh
- Jean El-CheikhJEJean El-Cheikh
- Stéphane MorissetSMStéphane Morisset
- Anne SirventASAnne Sirvent
- Oumedaly RemanOROumedaly Reman
- Jérôme CornillonJCJérôme Cornillon
- Reza TabriziRTReza Tabrizi
- Noel MilpiedNMNoel Milpied
- Jean-Luc HarousseauJHJean-Luc Harousseau
- Hélène LabussièreHLHélène Labussière
- Franck-Emmanuel NicoliniFNFranck-Emmanuel Nicolini
- 1 December 2013
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 41 (12) , 1008-1015
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-UpJournal of Clinical Oncology, 2011
- Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myelomaBlood, 2011
- Multiple MyelomaNew England Journal of Medicine, 2011
- International Myeloma Working Group Consensus Statement Regarding the Current Status of Allogeneic Stem-Cell Transplantation for Multiple MyelomaJournal of Clinical Oncology, 2010
- Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myelomaBlood, 2010
- Hematopoietic stem cell transplantation for multiple myeloma beyond 2010Blood, 2010
- Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allograftingBlood, 2009
- Improved survival in multiple myeloma and the impact of novel therapiesBlood, 2008
- Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myelomaBlood, 2006
- The role of immunomodulatory drugs in multiple myelomaSeminars in Hematology, 2003